Skip to main content

Advertisement

SpringerLink
Log in

Mapping Interests in Event-Driven and Long-Acting Pre-exposure Prophylaxis Formulations onto the HIV Risk Environment of Street-Based Female Sex Workers: A Latent Class Analysis

  • Original Paper
  • Published:
AIDS and Behavior Aims and scope Submit manuscript

Abstract

Despite growing availability, HIV pre-exposure prophylaxis (PrEP) uptake and adherence remains suboptimal among female sex workers (FSW) in the United States. Using cross-sectional data from a survey of 236 street-based cisgender FSW in Baltimore, Maryland, we examined interest in event-driven and long-acting PrEP formulations. Latent class analysis identified discrete patterns of interest in five novel PrEP agents. Multinomial latent class regression then examined factors associated with probabilistic class membership. A three-class solution emerged as the best-fit latent class model: Injectable Acceptors (~ 24% of sample), Universal Acceptors (~ 18%), and Non-Acceptors (~ 58%). Compared to Non-Acceptors, Universal Acceptors had significantly (p < 0.05) higher odds of reporting condomless vaginal sex with clients, client condom coercion, and client-perpetrated physical violence. Relative to Non-Acceptors, Injectable Acceptors were distinguished by significantly higher rates of condomless vaginal sex with clients and injection drug use. Expanding PrEP options for FSW could help overcome barriers to PrEP initiation and persistence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Data Availability

The data presented in this manuscript are available from the corresponding author upon request.

Code Availability

Not applicable.

References

  1. Centers for Disease Control and Prevention (CDC). HIV in the United States and dependent areas. Atlanta: CDC; 2020. https://www.cdc.gov/hiv/statistics/overview/ataglance.html. Accessed July 7, 2020.

  2. Huang YA. HIV preexposure prophylaxis, by race and ethnicity—United States, 2014–2016. Morb Mortal Wkly Rep. 2018;67. https://www.cdc.gov/mmwr/volumes/67/wr/mm6741a3.htm. Accessed July 7, 2020.

  3. Kuteesa MO, Seeley J, Weiss HA, Cook S, Kamali A, Webb EL. Alcohol misuse and illicit drug use among occupational groups at high risk of HIV in Sub-Saharan Africa: a systematic review. AIDS Behav. 2019;23(12):3199–225.

    Article  PubMed  Google Scholar 

  4. Kuteesa MO, Seeley J, Cook S, Webb EL. Multi-level experiences and determinants of alcohol misuse and illicit drug use among occupational groups at high-risk of HIV in Sub-Saharan Africa: a thematic synthesis of qualitative findings. Glob Public Health. 2020;15(5):715–33.

    Article  PubMed  Google Scholar 

  5. Goldenberg SM, Duff P, Krusi A. Work environments and HIV prevention: a qualitative review and meta-synthesis of sex worker narratives. BMC Public Health. 2015;15:1241.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Footer KH, Silberzahn BE, Tormohlen KN, Sherman SG. Policing practices as a structural determinant for HIV among sex workers: a systematic review of empirical findings. J Int AIDS Soc. 2016;19(4 Suppl 3):20883.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Platt L, Grenfell P, Meiksin R, Elmes J, Sherman SG, Sanders T, et al. Associations between sex work laws and sex workers’ health: a systematic review and meta-analysis of quantitative and qualitative studies. PLoS Med. 2018;15(12):e1002680.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Baral S, Beyrer C, Muessig K, Poteat T, Wirtz AL, Decker MR, et al. Burden of HIV among female sex workers in low-income and middle-income countries: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(7):538–49.

    Article  PubMed  Google Scholar 

  9. Dubbink JH, Verweij SP, Struthers HE, Ouburg S, McIntyre JA, Morré SA, et al. Genital Chlamydia trachomatis and Neisseria gonorrhoeae infections among women in Sub-Saharan Africa: a structured review. Int J STD AIDS. 2018;29(8):806–24.

    Article  PubMed  Google Scholar 

  10. Nerlander LM, Handanagic S, Hess KL, Lutnick A, Agnew-Brune CB, Hoots BE, et al. HIV prevalence among women who exchange sex for money or drugs-4 U.S. cities. J Acquir Immune Defic Syndr 1999. 2020;84(4):345–54.

    Article  Google Scholar 

  11. Wang Z, Lau JTF, Yang X, Cai Y, Gross DL, Ma T, et al. Acceptability of daily use of free oral pre-exposure prophylaxis (PrEP) among transgender women sex workers in Shenyang, China. AIDS Behav. 2017;21(12):3287–98.

    Article  PubMed  Google Scholar 

  12. Bazzi AR, Yotebieng K, Otticha S, Rota G, Agot K, Ohaga S, et al. PrEP and the syndemic of substance use, violence, and HIV among female and male sex workers: a qualitative study in Kisumu, Kenya. J Int AIDS Soc. 2019;22(4):e25266.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Glick JL, Russo R, Jivapong B, Rosman L, Pelaez D, Footer KHA, et al. The PrEP care continuum among cisgender women who sell sex and/or use drugs globally: a systematic review. AIDS Behav. 2019;24(5):1312–33.

    Article  Google Scholar 

  14. Poteat T, Wirtz A, Malik M, Cooney E, Cannon C, Hardy WD, et al. A gap between willingness and uptake: findings from mixed methods research on HIV prevention among Black and Latina transgender women. J Acquir Immune Defic Syndr 1999. 2019;82(2):131–40.

    Article  Google Scholar 

  15. Tomko C, Park JN, Allen ST, Glick J, Galai N, Decker MR, et al. Awareness and interest in HIV pre-exposure prophylaxis among street-based female sex workers: results from a US context. AIDS Patient Care STDs. 2019;33(2):49–57.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Deutsch MB, Glidden DV, Sevelius J, Keatley J, McMahan V, Guanira J, et al. HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial. Lancet HIV. 2015;2(12):e512-519.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Eakle R, Gomez GB, Naicker N, Bothma R, Mbogua J, Cabrera Escobar MA, et al. HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: results from a prospective observational demonstration project. PLoS Med. 2017;14(11):e1002444.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Kagaayi J, Batte J, Nakawooya H, Kigozi B, Nakigozi G, Strömdahl S, et al. Uptake and retention on HIV pre-exposure prophylaxis among key and priority populations in South-Central Uganda. J Int AIDS Soc. 2020;23(8):e25588.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Mutua G, Sanders E, Mugo P, Anzala O, Haberer JE, Bangsberg D, et al. Safety and adherence to intermittent pre-exposure prophylaxis (PrEP) for HIV-1 in African men who have sex with men and female sex workers. PLoS ONE. 2012;7(4):e33103.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Van Damme L, Corneli A, Ahmed K, Agot K, Lombaard J, Kapiga S, et al. Preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2012;367(5):411–22.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  21. Choopanya K, Martin M, Suntharasamai P, Sangkum U, Mock PA, Leethochawalit M, et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet Lond Engl. 2013;381(9883):2083–90.

    Article  Google Scholar 

  22. Marrazzo JM, Ramjee G, Richardson BA, Gomez K, Mgodi N, Nair G, et al. Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2015;372(6):509–18.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  23. Mack N, Evens EM, Tolley EE, Brelsford K, Mackenzie C, Milford C, et al. The importance of choice in the rollout of ARV-based prevention to user groups in Kenya and South Africa: a qualitative study. J Int AIDS Soc. 2014;17(3 Suppl 2):19157.

    PubMed  PubMed Central  Google Scholar 

  24. Ye L, Wei S, Zou Y, Abdullah AS, Zhong X, Ruan Y, et al. HIV pre-exposure prophylaxis interest among female sex workers in Guangxi, China. PLoS ONE. 2014;9(1):e86200.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  25. Reza-Paul S, Lazarus L, Doshi M, Hafeez Ur Rahman S, Ramaiah M, Maiya R, et al. Prioritizing risk in preparation for a demonstration project: a mixed methods feasibility study of oral pre-exposure prophylaxis (PREP) among female sex workers in South India. PLoS ONE. 2016;11(11):e0166889.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  26. Eakle R, Bourne A, Mbogua J, Mutanha N, Rees H. Exploring acceptability of oral PrEP prior to implementation among female sex workers in South Africa. J Int AIDS Soc. 2018;21(2):e25081.

    Article  PubMed Central  Google Scholar 

  27. Footer KHA, Lim S, Rael CT, Greene GJ, Carballa-Diéguez A, Giguere R, et al. Exploring new and existing PrEP modalities among female sex workers and women who inject drugs in a U.S. city. AIDS Care. 2019;31(10):1207–13.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Emmanuel G, Folayan M, Undelikwe G, Ochonye B, Jayeoba T, Yusuf A, et al. Community perspectives on barriers and challenges to HIV pre-exposure prophylaxis access by men who have sex with men and female sex workers access in Nigeria. BMC Public Health. 2020;20(1):69.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Van der Elst EM, Mbogua J, Operario D, Mutua G, Kuo C, Mugo P, et al. High acceptability of HIV pre-exposure prophylaxis but challenges in adherence and use: qualitative insights from a phase I trial of intermittent and daily PrEP in at-risk populations in Kenya. AIDS Behav. 2013;17(6):2162–72.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Eakle R, Bothma R, Bourne A, Gumede S, Motsosi K, Rees H. “I am still negative”: female sex workers’ perspectives on uptake and use of daily pre-exposure prophylaxis for HIV prevention in South Africa. PLoS ONE. 2019;14(4):e0212271.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Chakrapani V, Shunmugam M, Rawat S, Baruah D, Nelson R, Newman PA. Acceptability of HIV pre-exposure prophylaxis among transgender women in India: a qualitative investigation. AIDS Patient Care STDs. 2020;34(2):92–8.

    Article  PubMed  Google Scholar 

  32. Sherman SG, Park JN, Galai N, Allen ST, Huettner SS, Silberzahn BE, et al. Drivers of HIV infection among cisgender and transgender female sex worker populations in Baltimore City: results from the SAPPHIRE Study. J Acquir Immune Defic Syndr 1999. 2019;80(5):513–21.

    Article  Google Scholar 

  33. Lim S, Park JN, Kerrigan DL, Sherman SG. Severe food insecurity, gender-based violence, homelessness, and HIV risk among street-based female sex workers in Baltimore, Maryland. AIDS Behav. 2019;23(11):3058–63.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Nerlander LM, Hess KL, Rose CE, Sionean C, Thorson A, Broz D, et al. Exchange sex and HIV infection among women who inject drugs-20 US cities, 2009. J Acquir Immune Defic Syndr 1999. 2017;75(Suppl 3):S333–40.

    Article  Google Scholar 

  35. Hendrix CW. HIV antiretroviral pre-exposure prophylaxis: development challenges and pipeline promise. Clin Pharmacol Ther. 2018;104(6):1082–97.

    Article  PubMed  Google Scholar 

  36. Coelho LE, Torres TS, Veloso VG, Landovitz RJ, Grinsztejn B. Pre-exposure prophylaxis 2.0: new drugs and technologies in the pipeline. Lancet HIV. 2019;6(11):e788–99.

    Article  PubMed  Google Scholar 

  37. United States Public Health Service. Pre-exposure prophylaxis for the prevention of HIV infection in the United States—2017 update: a clinical practice guideline. Atlanta: Centers for Disease Control and Prevention (CDC); 2017. https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2017.pdf. Accessed July 7, 2020.

  38. HIV Prevention Trials Network. HPTN 084 study demonstrates superiority of CAB LA to oral FTC/TDF for the prevention of HIV. HPTN; 2020. https://www.hptn.org/news-and-events/press-releases/hptn-084-study-demonstrates-superiority-of-cab-la-to-oral-ftctdf-for.

  39. Luecke EH, Cheng H, Woeber K, Nakyanzi T, Mudekunye-Mahaka IC, van der Straten A, et al. Stated product formulation preferences for HIV pre-exposure prophylaxis among women in the VOICE-D (MTN-003D) study. J Int AIDS Soc. 2016;19(20875):1–9.

    Google Scholar 

  40. Harling G, Muya A, Ortblad KF, Mashasi I, Dambach P, Ulenga N, et al. HIV risk and pre-exposure prophylaxis interest among female bar workers in Dar es Salaam: cross-sectional survey. BMJ Open. 2019;9(3):e023272.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Hynes JS, Sales JM, Sheth AN, Lathrop E, Haddad LB. Interest in multipurpose prevention technologies to prevent HIV/STIs and unintended pregnancy among young women in the United States. Contraception. 2018;97(3):277–84.

    Article  PubMed  Google Scholar 

  42. Minnis AM, Browne EN, Boeri M, Agot K, van der Straten A, Ahmed K, et al. Young women’s stated preferences for biomedical HIV prevention: results of a discrete choice experiment in Kenya and South Africa. J Acquir Immune Defic Syndr 1999. 2019;80(4):394–403.

    Article  Google Scholar 

  43. Shapley-Quinn MK, Manenzhe KN, Agot K, Minnis AM, van der Straten A. “We are not the same”: African women’s view of multipurpose prevention products in the TRIO clinical study. Int J Womens Health. 2019;11:97–107.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. van den Berg JJ, Rosen RK, Bregman DE, Thompson LA, Jensen KM, Kiser PF, et al. “Set it and forget it”: women’s perceptions and opinions of long-acting topical vaginal gels. AIDS Behav. 2014;18(5):862–70.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Govender E, Abdool KQ. Understanding women and men’s acceptability of current and new HIV prevention technologies in KwaZulu-Natal, South Africa. AIDS Care. 2018;30(10):1311–4.

    Article  PubMed  Google Scholar 

  46. Eisingerich AB, Wheelock A, Gomez GB, Garnett G, Dybul MR, Piot PK. Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: a multinational study. PLoS ONE. 2012;7(1):e28238.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Minnis AM, Roberts ST, Agot K, Weinrib R, Ahmed K, Manenzhe K, et al. Young women’s ratings of three placebo multipurpose prevention technologies for HIV and pregnancy prevention in a randomized, cross-over study in Kenya and South Africa. AIDS Behav. 2018;22(8):2662–73.

    Article  PubMed  PubMed Central  Google Scholar 

  48. van der Straten A, Agot K, Ahmed K, Weinrib R, Browne EN, Manenzhe K, et al. The Tablets, Ring, Injections as Options (TRIO) study: what young African women chose and used for future HIV and pregnancy prevention. J Int AIDS Soc. 2018;21(3):e25094.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  49. Allen ST, Footer KHA, Galai N, Park JN, Silberzahn B, Sherman SG. Implementing targeted sampling: lessons learned from recruiting female sex workers in Baltimore, MD. J Urban Health Bull N Y Acad Med. 2019;96(3):442–51.

    Article  Google Scholar 

  50. Silberzahn BE, Morris MB, Riegger KE, White RH, Tomko CA, Park JN, et al. Barriers and facilitators to retaining a cohort of street-based cisgender female sex workers recruited in Baltimore, Maryland, USA: results from the SAPPHIRE study. BMC Public Health. 2020;20(1):585.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Rhodes T. The, “risk environment”: a framework for understanding and reducing drug-related harm. Int J Drug Policy. 2002;13(2):85–94.

    Article  Google Scholar 

  52. Footer KHA, Park JN, Allen ST, Decker MR, Silberzahn BE, Huettner S, et al. Police-related correlates of client-perpetrated violence among female sex workers in Baltimore City, Maryland. Am J Public Health. 2019;109(2):289–95.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Brantley M, Kerrigan D, German D, Lim S, Sherman S. Identifying patterns of social and economic hardship among structurally vulnerable women: a latent class analysis of HIV/STI risk. AIDS Behav. 2017;21(10):3047–56.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Footer KHA, Lim S, Brantley MR, Sherman SG. Structural risk and limits on agency among exotic dancers: HIV risk practices in the exotic dance club. Cult Health Sex. 2018;20(3):321–34.

    Article  PubMed  Google Scholar 

  55. Straus MA, Hamby SL, Boney-McCoy S, Sugarman DB. The revised Conflict Tactics Scales (CTS2): development and preliminary psychometric data. J Fam Issues. 1996;17(3):283–316.

    Article  Google Scholar 

  56. Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med. 1998;158(16):1789–95.

    Article  CAS  PubMed  Google Scholar 

  57. Collins LM, Lanza ST. Latent class and latent transition analysis: with applications in the social, behavioral, and health sciences. New York: Wiley; 2009.

    Book  Google Scholar 

  58. Lanza ST, Collins LM, Lemmon DR, Schafer JL. PROC LCA: a SAS procedure for latent class analysis. Struct Equ Model Multidiscip J. 2007;14(4):671–94.

    Article  Google Scholar 

  59. Goodman LA. Exploratory latent structure analysis using both identifiable and unidentifiable models. Biometrika. 1974;61(2):215–31.

    Article  Google Scholar 

  60. Celeux G, Soromenho G. An entropy criterion for assessing the number of clusters in a mixture model. J Classif. 1996;13(2):195–212.

    Article  Google Scholar 

  61. Lo Y, Mendell NR, Rubin DB. Testing the number of components in a normal mixture. Biometrika. 2001;88(3):767–78.

    Article  Google Scholar 

  62. McCutcheon AL. Latent class analysis. Thousand Oaks: SAGE; 1987.

    Book  Google Scholar 

  63. McLachlan GJ. Mahalanobis distance. Resonance. 1999;4(6):20–6.

    Article  Google Scholar 

  64. Nagin D. Group-based modeling of development. Cambridge: Harvard University Press; 2009.

    Google Scholar 

  65. Vermunt JK. Latent class modeling with covariates: two improved three-step approaches. Polit Anal Undefined/ed. 2017;18(4):450–69.

    Article  Google Scholar 

  66. Rael CT, Martinez M, Giguere R, Bockting W, MacCrate C, Mellman W, et al. Transgender women’s concerns and preferences on potential future long-acting biomedical HIV prevention strategies: the case of injections and implanted medication delivery devices (IMDDs). AIDS Behav. 2019;24(5):1452–62.

    Article  Google Scholar 

  67. Ma PHX, Chan ZCY, Loke AY. The socio-ecological model approach to understanding barriers and facilitators to the accessing of health services by sex workers: a systematic review. AIDS Behav. 2017;21(8):2412–38.

    Article  PubMed  Google Scholar 

  68. Croxford S, Platt L, Hope VD, Cullen KJ, Parry JV, Ncube F. Sex work amongst people who inject drugs in England, Wales and Northern Ireland: findings from a National Survey of Health Harms and Behaviours. Int J Drug Policy. 2015;26(4):429–33.

    Article  PubMed  Google Scholar 

  69. Girchenko P, King EJ. Correlates of double risk of HIV acquisition and transmission among women who inject drugs in St. Petersburg, Russia. AIDS Behav. 2017;21(4):1054–8.

    Article  PubMed  Google Scholar 

  70. Park JN, Footer KHA, Decker MR, Tomko C, Allen ST, Galai N, et al. Interpersonal and structural factors associated with receptive syringe-sharing among a prospective cohort of female sex workers who inject drugs. Addict Abingdon Engl. 2019;114(7):1204–13.

    Article  Google Scholar 

  71. Adelekan AL, Omoregie PI, Edoni ER. Sexual practices of female sex workers who inject drugs in Osogbo, Nigeria. Int Sch Res Not. 2014;2014. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4897494/ (cited 1 Oct 2020).

  72. Wirtz AL, Peryshkina A, Mogilniy V, Beyrer C, Decker MR. Current and recent drug use intensifies sexual and structural HIV risk outcomes among female sex workers in the Russian Federation. Int J Drug Policy. 2015;26(8):755–63.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Biello KB, Bazzi AR, Mimiaga MJ, Biancarelli DL, Edeza A, Salhaney P, et al. Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs. Harm Reduct J. 2018;15. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6233595/ (cited 1 Oct 2020).

  74. Allen ST, O’Rourke A, White RH, Smith KC, Weir B, Lucas GM, et al. Barriers and facilitators to PrEP use among people who inject drugs in rural Appalachia: a qualitative study. AIDS Behav. 2020;24(6):1942–50.

    Article  PubMed  PubMed Central  Google Scholar 

  75. Schneider KE, White RH, O’Rourke A, Kilkenny ME, Perdue M, Sherman SG, et al. Awareness of and interest in oral pre-exposure prophylaxis (PrEP) for HIV prevention and interest in hypothetical forms of PrEP among people who inject drugs in rural West Virginia. AIDS Care. 2020;21:1–8.

    Google Scholar 

  76. Atujuna M, Newman PA, Wallace M, Eluhu M, Rubincam C, Brown B, et al. Contexts of vulnerability and the acceptability of new biomedical HIV prevention technologies among key populations in South Africa: a qualitative study. PLoS ONE. 2018;13(2):e0191251.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  77. Woodsong C, Alleman P. Sexual pleasure, gender power and microbicide acceptability in Zimbabwe and Malawi. AIDS Educ Prev Off Publ Int Soc AIDS Educ. 2008;20(2):171–87.

    Article  Google Scholar 

  78. Gafos M, Pool R, Mzimela MA, Ndlovu HB, McCormack S, Elford J. Communication about microbicide use between couples in KwaZulu-Natal, South Africa. AIDS Behav. 2015;19(5):832–46.

    Article  PubMed  Google Scholar 

  79. Robertson AM, Syvertsen JL, Martinez G, Rangel MG, Palinkas LA, Stockman JK, et al. Acceptability of vaginal microbicides among female sex workers and their intimate male partners in two Mexico–US border cities: a mixed methods analysis. Glob Public Health. 2013;8(5):619–33.

    Article  PubMed  PubMed Central  Google Scholar 

  80. Giguere R, Frasca T, Dolezal C, Febo I, Cranston RD, Mayer K, et al. Acceptability of three novel HIV prevention methods among young male and transgender female sex workers in Puerto Rico. AIDS Behav. 2016;20(10):2192–202.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank all the women who participated in this study as well as study staff who oversaw data collection.

Funding

This study was supported by the National Institute on Drug Abuse (R01DA038499-01) and the Johns Hopkins University Center for AIDS Research (1P30AI094189). KES was supported by a Training Grant from the National Institute on Drug Abuse (5T32DA007292).

Author information

Authors and Affiliations

  1. Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA

    Joseph G. Rosen & S. Wilson Beckham

  2. Department of Health, Behavior, and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA

    Ju Nyeong Park, Rebecca Hamilton White, S. Wilson Beckham, Jennifer L. Glick, Katherine H. A. Footer & Susan G. Sherman

  3. Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA

    Kristin E. Schneider

  4. Department of Health, Behavior, and Society, Johns Hopkins Bloomberg School of Public Health, 624 N. Broadway Street, Hampton House Suite 749, Baltimore, MD, 21205, USA

    Susan G. Sherman

Authors
  1. Joseph G. Rosen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ju Nyeong Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kristin E. Schneider
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rebecca Hamilton White
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Wilson Beckham
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jennifer L. Glick
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Katherine H. A. Footer
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Susan G. Sherman
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

KHAF and SGS developed the study protocol and secured funding for the study. JNP, RHW, KHAF, and SGS oversaw data collection. JGR led data analysis, with input from JNP, KES, and SGS. All authors contributed to results interpretation and preparation of the final manuscript.

Corresponding author

Correspondence to Joseph G. Rosen.

Ethics declarations

Conflict of interest

The authors have no conflicts to declare.

Ethical Approval

The study was approved by the Johns Hopkins Bloomberg School of Public Health IRB.

Informed Consent

Participants provided written informed consent prior to study procedures.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rosen, J.G., Park, J.N., Schneider, K.E. et al. Mapping Interests in Event-Driven and Long-Acting Pre-exposure Prophylaxis Formulations onto the HIV Risk Environment of Street-Based Female Sex Workers: A Latent Class Analysis. AIDS Behav 26, 1992–2002 (2022). https://doi.org/10.1007/s10461-022-03613-9

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10461-022-03613-9

Keywords

Search

Navigation